Application of GQSAR for Scaffold Hopping and Lead Optimization in Multitarget Inhibitors

被引:18
作者
Ajmani, Subhash [1 ]
Kulkarni, Sudhir A. [1 ,2 ]
机构
[1] NovaLead Pharma Pvt Ltd, Pride Purple Coronet, Pune 411045, Maharashtra, India
[2] VLife Sci Technol Pvt Ltd, Pride Purple Coronet, Pune 411045, Maharashtra, India
关键词
Group based QSAR; Scaffold hopping; Lead optimization; Multitarget inhibitors; DESIGNING MULTIPLE LIGANDS; PROTEIN-KINASE INHIBITORS; DRUG DISCOVERY; NETWORK PERSPECTIVES; REUPTAKE INHIBITORS; QSPR MODELS; MECHANISMS; DATABASE; QSAR; ANTIDEPRESSANTS;
D O I
10.1002/minf.201100160
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Many literature reports suggest that drugs against multiple targets may overcome many limitations of single targets and achieve a more effective and safer control of the disease. However, design of multitarget drugs presents a great challenge. The present study demonstrates application of a novel Group based QSAR (GQSAR) method to assist in lead optimization of multikinase (PDGFR-beta, FGFR-1 and SRC) and scaffold hopping of multiserotonin target (serotonin receptor 1A and serotonin transporter) inhibitors. For GQSAR analysis, a wide variety of structurally diverse multikinase inhibitors (225 molecules) and multiserotonin target inhibitors (162 molecules) were collected from various literature reports. Each molecule in the data set was divided into four fragments (kinase inhibitors) and three fragments (serotonin target inhibitors) and their corresponding two-dimensional fragment descriptors were calculated. The multiresponse regression GQSAR models were developed for both the datasets. The developed GQSAR models were found to be useful for scaffold hopping and lead optimization of multitarget inhibitors. In addition, the developed GQSAR models provide important fragment based features that can form the building blocks to guide combinatorial library design in the search for optimally potent multitarget inhibitors.
引用
收藏
页码:473 / 490
页数:18
相关论文
共 50 条
[41]   Lead optimization, pharmacophore development and scaffold design of protein kinase CK2 inhibitors as potential COVID-19 therapeutics [J].
Yadav, Siddharth ;
Ahamad, Shahzaib ;
Gupta, Dinesh ;
Mathur, Puniti .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (05) :1811-1827
[42]   Nipah virus G attachment protein inhibitors from Streptomyces spp. and optimization of a lead peptide scaffold through in silico approaches [J].
Dulay, Albert Neil G. ;
de Guzman, John Christian C. ;
Odchimar, Nyzar Mabeth O. ;
Orosco, Fredmoore L. .
BIOLOGIA, 2025, 80 (03) :715-739
[43]   Lead optimization of cathepsin K inhibitors for the treatment of Osteoarthritis [J].
Ginnetti, Anthony T. ;
Paone, Daniel, V ;
Nanda, Kausik K. ;
Li, Jing ;
Busuek, Marina ;
Johnson, Scott A. ;
Lu, Jun ;
Soisson, Stephen M. ;
Robinson, Ronald ;
Fisher, John ;
Webber, Andrea ;
Wesolowski, Gregg ;
Ma, Bennett ;
Le Duong ;
Carroll, Steven ;
Burgey, Christopher S. ;
Stachel, Shawn J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 74
[44]   Lead identification and optimization of bacterial glutamate racemase inhibitors [J].
Malapati, Prasanthi ;
Krishna, Vagolu Siva ;
Nallangi, Radhika ;
Meda, Nikhila ;
Srilakshmi, Rudraraju Reshma ;
Sriram, Dharmarajan .
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (01) :177-190
[45]   An in-silico scaffold- hopping approach to design novel inhibitors against gp130: A potential therapeutic application in cancer and Covid-19 [J].
Roy, Alankar ;
Paul, Ishani ;
Luharuka, Shreya ;
Ray, Sujay .
MOLECULAR DIVERSITY, 2024, 28 (05) :3129-3151
[46]   Discovery of NR2B-selective antagonists via scaffold hopping and pharmacokinetic profile optimization [J].
Anan, Kosuke ;
Masui, Moriyasu ;
Tazawa, Aya ;
Tomida, Minoru ;
Haga, Yoshihiro ;
Kume, Masaharu ;
Yamamoto, Shoichi ;
Shinohara, Shunji ;
Tsuj, Hiroki ;
Shimada, Shinji ;
Yagi, Shigenori ;
Hasebe, Nobuyoshi ;
Kai, Hiroyuki .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (09) :1143-1147
[47]   Identification of DDR1 Inhibitors from Marine Compound Library Based on Pharmacophore Model and Scaffold Hopping [J].
Hu, Honghui ;
Tao, Jiahua ;
Luo, Lianxiang .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (03)
[48]   Scaffold hopping in the rational design of novel HIV-1 non-nucleoside reverse transcriptase inhibitors [J].
O'Meara, Jeff A. ;
Jakalian, Araz ;
LaPlante, Steven ;
Bonneau, Pierre R. ;
Coulombe, Rene ;
Faucher, Anne-Marie ;
Guse, Ingrid ;
Landry, Serge ;
Racine, Jennifer ;
Simoneau, Bruno ;
Thavonekham, Bounkham ;
Yoakim, Christiane .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (12) :3362-3366
[49]   Identifying novel putative ERK1/2 inhibitors via hybrid scaffold hopping -FBDD approach [J].
Pathania, Shelly ;
Singh, Pankaj Kumar ;
Narang, Raj Kumar ;
Rawal, Ravindra K. .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (15) :6771-6786
[50]   A Study in Scaffold Hopping: Discovery and Optimization of Thiazolopyridines as Potent Herbicides That Inhibit Acyl-ACP Thioesterase [J].
Abel, Steven A. G. ;
Alnafta, Neanne ;
Asmus, Elisabeth ;
Bollenbach-Wahl, Birgit ;
Braun, Ralf ;
Dittgen, Jan ;
Endler, Anne ;
Frackenpohl, Jens ;
Freigang, Joerg ;
Gatzweiler, Elmar ;
Heinemann, Ines ;
Helmke, Hendrik ;
Laber, Bernd ;
Lange, Gudrun ;
Machettira, Anu ;
Mcarthur, Gillian ;
Mueller, Thomas ;
Odaybat, Magdalena ;
Reingruber, Anna M. ;
Roth, Sina ;
Rosinger, Christopher H. ;
Schmutzler, Dirk ;
Schulte, Wolfgang ;
Stoppel, Rhea ;
Tiebes, Joerg ;
Volpin, Giulio ;
Barber, David M. .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2023, 71 (47) :18212-18226